Free Trial

Jamieson Wellness (TSE:JWEL) Shares Down 0.4% - Time to Sell?

Jamieson Wellness logo with Consumer Defensive background

Jamieson Wellness Inc. (TSE:JWEL - Get Free Report)'s stock price fell 0.4% during trading on Tuesday . The stock traded as low as C$35.10 and last traded at C$35.52. 52,108 shares were traded during mid-day trading, a decline of 27% from the average session volume of 71,392 shares. The stock had previously closed at C$35.68.

Wall Street Analysts Forecast Growth

Separately, Royal Bank Of Canada increased their price objective on Jamieson Wellness from C$40.00 to C$42.00 in a research note on Friday, May 9th.

Read Our Latest Analysis on JWEL

Jamieson Wellness Price Performance

The stock's 50 day moving average is C$34.70 and its two-hundred day moving average is C$33.19. The stock has a market capitalization of C$1.47 billion, a PE ratio of 36.97 and a beta of 0.63. The company has a debt-to-equity ratio of 75.70, a current ratio of 2.76 and a quick ratio of 1.08.

Insider Activity

In other news, Senior Officer Regan Stewart sold 7,044 shares of the firm's stock in a transaction on Friday, May 30th. The shares were sold at an average price of C$35.28, for a total value of C$248,510.91. Also, Senior Officer Paul Michael Galbraith sold 1,044 shares of Jamieson Wellness stock in a transaction on Monday, May 26th. The stock was sold at an average price of C$35.06, for a total transaction of C$36,603.06. Over the last quarter, insiders have sold 46,959 shares of company stock worth $1,651,365. Insiders own 0.26% of the company's stock.

Jamieson Wellness Company Profile

(Get Free Report)

Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment.

Further Reading

Should You Invest $1,000 in Jamieson Wellness Right Now?

Before you consider Jamieson Wellness, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jamieson Wellness wasn't on the list.

While Jamieson Wellness currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines